The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.
暂无分享,去创建一个
A. Nicholson | D. Hansell | T. Colby | R. D. du Bois | A. Wells | A. Wells | R. Dubois
[1] J. Myers,et al. Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria. , 2000, The American journal of surgical pathology.
[2] W. Travis,et al. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. , 2000, The American journal of surgical pathology.
[3] A. Nicholson,et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. , 1999, American journal of respiratory and critical care medicine.
[4] T. Colby,et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. , 1998, The European respiratory journal.
[5] J. Myers,et al. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.
[6] R. Hubbard,et al. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. , 1998, Chest.
[7] K P Offord,et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[8] M. Akira,et al. Serial computed tomographic evaluation in desquamative interstitial pneumonia. , 1997, Thorax.
[9] I. D. Johnston,et al. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. , 1997, Thorax.
[10] A. Nicholson,et al. Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. , 1996, Clinical radiology.
[11] N. Müller,et al. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. , 1996, Chest.
[12] R. Wu,et al. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. , 1995, Chest.
[13] D. Hansell,et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. , 1994, American journal of respiratory and critical care medicine.
[14] C D Collins,et al. Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. , 1994, Clinical radiology.
[15] A. Katzenstein,et al. Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance , 1994, The American journal of surgical pathology.
[16] D M Hansell,et al. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. , 1993, AJR. American journal of roentgenology.
[17] P. Bardin,et al. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. , 1991, Thorax.
[18] M. Kitaichi. Pathologic features and the classification of interstitial pneumonia of unknown etiology. , 1990, Bulletin of the Chest Disease Research Institute, Kyoto University.
[19] T. Chinet,et al. Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA. , 1990, The American review of respiratory disease.
[20] T. Colby,et al. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. , 1989, Mayo Clinic proceedings.
[21] J. Darbyshire,et al. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. , 1989, Thorax.
[22] F. Ognibene,et al. Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). , 1988, Annals of internal medicine.
[23] G. Raghu. Idiopathic pulmonary fibrosis. A rational clinical approach. , 1987, Chest.
[24] J. Myers,et al. Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. , 1987, The American review of respiratory disease.
[25] J. Myers,et al. Acute Interstitial Pneumonia: A Clinicopathologic, Ultrastmctural, and Cell Kinetic Study , 1986, The American journal of surgical pathology.
[26] R. Crystal,et al. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. , 1984, The New England journal of medicine.
[27] E. Taskinen,et al. Prognosis of cryptogenic fibrosing alveolitis. , 1983, Thorax.
[28] V. Ferrans,et al. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. , 1981, The American journal of medicine.
[29] B. Burrows,et al. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.
[30] B. Burrows,et al. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.
[31] R G Gupta,et al. Natural history and treated course of usual and desquamative interstitial pneumonia. , 1978, The New England journal of medicine.
[32] A. Fishman. UIP, DIP, and all that. , 1978, The New England journal of medicine.
[33] B. Heard,et al. The prognosis of cryptogenic fibrosing alveolitis , 1972, British medical journal.
[34] W. Roberts,et al. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. , 1976, Annals of internal medicine.
[35] J. Scadding,et al. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs) , 1967, Thorax.
[36] L. Woolner,et al. Pulmonary fibrosis. , 1954, The Medical clinics of North America.